Pharmaceutical firm Haisco agreed on Monday to invest $10m in Pneuma Respiratory, a US-based company developing a breath-activated digital inhaler, as part of an agreement that will allow it to distribute Pneuma’s products in China. The investment came after Pneuma raised $8.3m in series A financing from undisclosed investors last month, and the company has not publicly disclosed earlier funding.
Owl Cameras, a US-based in-car video technology developer backed by financial services and insurance provider CSAA, raised $10m on Tuesday…
